Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? PTC Inc. (PTC) , which belongs to the Zacks Computer - Software industry, could be a great candidate to consider.When looking at the last two reports, this product development software maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 15.98%, on average, in the last two quarters.For the last report ...

NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PTC and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action]                 ...

kentoh/iStock via Getty Images Investment Outlook PTC Inc. (NASDAQ:PTC) provides a wide array of lifecycle management software and services to various industries worldwide. I previously wrote about PTC in May 2023 with a Hold outlook due to flat organic bookings growth. Despite a challenging sales environment for transformational deals, the company has produced revenue and earnings growth as it works to maximize value from its 2023 acquisition of ServiceMax. While PTC Inc. stock isn’t cheap, my outlook ...

BOSTON, July 11, 2024 /PRNewswire/ -- PTC (Nasdaq: PTC) will release its fiscal 2024 third quarter results on Wednesday, July 31st after the stock market closes. Senior management will host a live webcast and conference call to review the results on Wednesday, July 31st at 5pm Eastern Time. The earnings press release, accompanying earnings presentation, and financial data tables will be accessible prior to the conference call and webcast on the Investor Relations section of the Company's website at PTC Inve ...

NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether PTC and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 28, 2024, PTC issued ...

文章核心观点 - 机器人行业市场规模有望从2024年的$45.85亿增长到2029年的$95.93亿,增长率达15.91% [1] - 美国机器人行业市场规模有望在2024年达到$7.85亿,成为全球最大市场 [1] - 机器人行业受到机构投资者的青睐,主要得益于拜登总统2024年颁布的人工智能行政命令,旨在推进人工智能技术的发展,确保其安全性、安全性和公平性 [2] - 机器人技术正在不断进步,如NVIDIA、比亚迪和Teradyne的合作使机器人具备自主驾驶、协作等人工智能和建模能力 [2] - 人形机器人正在改善医疗和工作环境,如亚马逊和宝马使用这些机器人来执行危险或重复性的任务,提高安全性和效率 [3] - 工业外骨骼预计到2030年将增长7倍,帮助工人在搬运重物或重复活动时避免损伤和疲劳 [4] 行业发展 - 机器人行业市场规模有望从2024年的$45.85亿增长到2029年的$95.93亿,增长率达15.91% [1] - 美国机器人行业市场规模有望在2024年达到$7.85亿,成为全球最大市场 [1] - 机器人技术正在不断进步,如NVIDIA、比亚迪和Teradyne的合作使机器人具备自主驾驶、协作等人工智能和建模能力 [2] - 人形机器人正在改善医疗和工作环境,如亚马逊和宝马使用这些机器人来执行危险或重复性的任务,提高安全性和效率 [3] - 工业外骨骼预计到2030年将增长7倍,帮助工人在搬运重物或重复活动时避免损伤和疲劳 [4] 公司发展 Teradyne (TER) - Teradyne是一家测试机器人和工业自动化的领先公司,过去12个季度每个季度的收益都超过预期,并且在工业机器人市场份额持续增长 [6] - Teradyne 2024年第一季度业绩强劲,营收达$599.82亿,超过预期$566.31亿;每股收益51美分,也超过预期33美分 [7] - Teradyne已经发货8,000台J750动力测试设备,这一里程碑显示了公司在半导体测试和自主测试能力方面的专长 [8] - Teradyne正在通过与NVIDIA的合作,将人工智能技术应用于其机器人产品,如Universal Robots和MiR1200托盘搬运车,提升路径规划和自主导航能力 [9] - Teradyne新任命的首席人工智能官James Davidson,其在人工智能和机器人领域的专业知识,可能会为公司的移动机器人业务带来新的想法 [10] Symbotic (SYM) - Symbotic提供仓库自动化解决方案,其基于人工智能的供应链机器人技术,使其过去4个季度的利润超预期801%至901% [12] - Symbotic 2024财年第二季度营收达$424.3亿,超过预期$412.9亿,但每股亏损7美分,未达预期5美分盈利 [13] - 分析师预计Symbotic 2024财年每股利润将从2美分上调至40美分,并给予其买入评级,主要得益于收入和毛利率的增长 [14] - Symbotic不断改进和拓展产品,如GreenBox联合项目和BreakPack解决方案,以保持利润增长势头,并帮助公司拓展更多客户 [15] - 凭借其技术创新和快速增长,Symbotic被评为2024年全球最具创新力公司之一 [16] PTC (PTC) - PTC是计算机辅助设计领域的领导者,提供3D、VR和AR等仿真软件,连续8年实现盈利,是一家值得关注的机器人股票 [17] - PTC 2024年第二季度每股收益$1.10,超过预期$0.87;营收$603.07亿,也超过预期$575.53亿 [17] - PTC在2,279家公司中排名前32%,显示其在竞争激烈的领域具有竞争优势和稳定性,分析师给予其强烈买入评级,12个月目标价约为$191,较当前价格$178高8% [18] - PTC在工业物联网、CAD等多个领域获得行业权威机构的认可,如连续5年获得Quadrant Knowledge Solutions的IIoT SPARK Matrix第一名 [19] - PTC的Windchill和Codebeamer等工具被大众汽车集团等大型企业广泛应用于工程和产品生命周期管理 [20]

These two companies are strongly connected, but one is doing a much better job of giving guidance than the other and has a more resilient business model.Industrial software company PTC (PTC 0.32%) and Rockwell Automation (ROK 0.42%) are strategic partners and share many of the same end-market drivers. When the industrials sector wants to invest in automation and the digital technology that drives it, both companies benefit, and when it pulls back, both companies suffer. Yet right now, PTC is a stock worth b ...

WARREN, N.J., June 21, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 17, 2024, the company approved non-statutory stock options to purchase an aggregate of 1,380 shares of its common stock and 6,260 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to nine new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires' employment compensation.The ...

--New App Empowers Engineers and Designers to Validate Manufacturability, Optimize Designs, and Accelerate Speed to Market-- --Leverages Proprietary Artificial Intelligence (AI) Algorithms-- ITASCA, Ill., June 10, 2024 /PRNewswire/ -- SyBridge Technologies, a global leader in design and manufacturing solutions, today announced the launch of SyBridge Studio, a state-of-the-art manufacturing insights application, now available on the PTC Onshape® App Store. This advanced tool integrates a comprehensive suite ...

WARREN, N.J., May 29, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference: William Blair's 44th Annual Growth Stock Conference Tuesday, June 4, at 9:00 am ET / 8:00 am CT The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It ...